Results 101 to 110 of about 2,195 (197)

Effectiveness and Safety of Recombinant Zoster Vaccine in Rheumatic Diseases: Real-World Evidence from a Single-Centre Italian Cohort

Vaccines
Background: Patients with rheumatic diseases (RMDs) are at increased risk of herpes zoster (HZ), particularly when receiving immunosuppressive treatment.
Silvia Valentini, Jurgen Sota, Irene Fineschi, Edoardo Conticini, Estrella Garcia-Gonzalez, Emilio D’Ignazio, Marco Bardelli, Stefano Gentileschi, Marta Fabbroni, Francesca Bellisai, Paolo Falsetti, Enrico Selvi, Luca Cantarini, Bruno Frediani, Caterina Baldi   +14 more
doaj   +1 more source

Recommendations for vaccination against shingles [PDF]

Introduction and purpose: Shingles, or herpes zoster, is a painful condition caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox.
Pyla, Eliza, Zamachowska, Wiktoria, Zuzanna Wyleciał, Ząber, Julia   +3 more
core   +1 more source

Logistic and organizational barriers to herpes zoster vaccination in europe: A systematic review [PDF]

Background: The Herpes Zoster (HZ) poses a significant public health threat, leading to morbidity and occasional mortality in unvaccinated adults aged 50 and older.
Belpiede, Alessandro, Fiorilla, Claudio, Mercogliano, Michelangelo, Palladino, Raffale, Sorrentino, Michele, Triassi, Maria   +5 more
core   +1 more source

Evaluation of Shingrix vaccine against Herpes Zoster ; Supplement

, 2022
55 p. ill., APPENDIX REPORT 1 -- APPENDIX 1. BURDEN OF DISEASE 5 -- APPENDIX 1.1. SEARCH STRING FOR RETRIEVAL OF SYSTEMATIC REVIEWS 5 -- APPENDIX 1.2. SEARCH STRING FOR RETRIEVAL OF PRIMARY STUDIES 5 -- APPENDIX 1.3. PROPORTION OF HZ PATIENTS RECEIVING A TREATMENT IN SCIENSANO, GP SENTINEL NETWORK 7 -- APPENDIX 1.4.
openaire   +1 more source

Administering Shingles Vaccine Prior to the Initiation of Biologics Therapy: A Systematic Review [PDF]

Background: Shingles, also known as herpes zoster, is a viral infection caused by the varicella-zoster virus. The classic feature is a painful dermatomal rash.
Byrne, Nicola, Kelly, James, Khan, Dan, Lafferty, Fiona, Nasrudin, Ayub, O’Rourke, Niall, Ryan, Alicia, Semenov, Serhiy, Soo, Alex   +8 more
core   +1 more source

Evaluatie van het Shingrix vaccin tegen ZONA ; – Samenvatting

, 2022
26 p. ill., Zona is een pijnlijke ziekte die veroorzaakt wordt door een reactivatie van het windpokkenvirus. In de meerderheid van de gevallen geneest zona spontaan binnen 2 à 4 weken. Maar er kunnen zich wel complicaties voordoen, zoals postherpetische neuralgie (10 à 20% van de gevallen van zona).
openaire   +1 more source

Equity research: GlaxoSmithKline strategy and forecast [PDF]

, 2020
As we are living in a Covid-19 spreading environment, people can never feel more important and vulnerable the health itself is. Naturally, we feel interested to do an equity research on a healthcare company.
Wei, Zirui
core  

Zoster vaccination [PDF]

PB13 ...

core  

Évaluation du vaccin Shingrix contre le Zona ; – Synthèse

, 2022
28 p. ill., Le zona est une maladie douloureuse provoquée par une réactivation du virus de la varicelle. Dans la plupart des cas, il guérit spontanément en 2 à 4 semaines. Il peut toutefois avoir des complications, comme la névralgie post-herpétique (10 à 20 % des cas de zona), ou d’autres complications plus rares mais aussi plus graves. Le zona touche
openaire   +1 more source

Acute Immune Thrombocytopenia following administration of Shingrix recombinant zoster vaccine [PDF]

American Journal of Hematology, 2021
Nicholas Schmidt, Hillary Maitland
openaire   +1 more source